The Basics of Electroretinogram Testing
An electroretinogram (ERG) is a diagnostic test that measures the electrical activity of the retina in response to a light stimulus. The retina contains two types of photoreceptor cells - rods and cones. Rods are responsible for peripheral and night vision while cones provide color vision and detail. ERG testing helps ophthalmologists evaluate the function of both rods and cones to detect retinal abnormalities.
During an ERG exam, electrodes are placed on the surface of the anesthetized eye and small light flashes are shone on the retina. The responses generated by the photoreceptor cells and retinal neurons are recorded through the electrodes as wavelike deflections on an instrument called an Global Electroretinogram. Different testing protocols isolate the function of either rods, cones or both. Abnormal ERG results can reveal issues like retinal detachment, retinal diseases, optic nerve problems and inherited retinal conditions.
The Growing Global Patient Population
Diseases that impair retinal function are on the rise worldwide due to an aging global population and increased prevalence of conditions like diabetes. According to the World Health Organization, over 422 million people have diabetes and 1.6 million deaths are directly attributed to diabetes each year globally. Both diabetes and age-related macular degeneration are leading causes of visual impairment that can benefit from ERG screening.
Advances in genetic testing have also improved identification of inherited retinal dystrophies globally. Over 2.5 million people are affected by retinitis pigmentosa alone. Regular ERG monitoring helps track disease progression in these patients and guides treatment decisions. The expanding patient population is driving increased diagnostic ERG usage.
Key Regions Driving Market Growth
North America currently dominates the ERG device market owing to rapid technological adoption, supportive insurance policies and presence of leading manufacturers. The U.S holds the largest share of over 35% of the global market. However, Asia-Pacific is emerging as the fastest growing region due to its huge population, growing medical infrastructure and increasing healthcare spending in countries like China and India.
By 2027, the Asia-Pacific ERG devices market is expected grow at a CAGR of over 7% to reach a value of $30 million. Japan also has a sizeable market share due to its vision of universal health coverage and super-aged society prone to retinal diseases. Meanwhile, Europe and other developed markets continue growing at a steady rate to support clinical research and diagnostic needs.
New Product Options Expand Capabilities
Advances in ERG technology have introduced portable devices, improved software, user-friendly interfaces and new testing methodologies. Portable ERGs allow examination of pediatric patients and in-home monitoring of disease progression. Simultaneous photography and ERG functions provide correlation of functional and structural changes. Combined ERG-visual evoked potential devices suit multi-specialty diagnostic requirements.
Advent of full-field and multifocal ERG techniques supplement standard testing. Companies offer cloud-based data management and remote access capabilities tailored for clinical research applications. Wearable ERG sensors connected to smartphones are under development to enable mass screening and tele-medicine-based care. These expanded capabilities are augmenting clinical utility of ERG globally.
Purchasing Trends and Cost Considerations
Top players in the ERG market include LKC Technologies, Diagnosys LLC, Electro-Diagnostic Imaging, Diopsys and Metrovision. Most hospitals and eye clinics purchase ERG systems outright while research organizations tend to rent high-end devices. Maintenance contracts help optimize the technology investment over the product life cycle.
Standard ERG equipment costs $25,000-$150,000 depending on features. But newer portable devices range between $15,000 to $30,000, enhancing accessibility. Overall procedure charges including equipment rental, technician time and physician fees range from $500 to $3,000 based on the site of service. Public and private insurers are increasingly approving reimbursement claims for medically necessary ERG testing globally.
The global ERG device market provides lucrative opportunities for stakeholders due to the growing worldwide prevalence of retinal conditions. Advancements expanding clinical utility and the emerging Asia-Pacific region will be key market drivers. Uptake depends on financing support through insurance approvals and government healthcare programs optimizing accessibility. Manufacturers differentiating offerings will remain competitive in this specialized ophthalmic technology sector.
Get more insights on Global Electroretinogram
Comments
0 comment